These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 4082353)

  • 1. [Cardiovascular complications, lipoprotein metabolism and oral contraceptives].
    Gagné C
    Union Med Can; 1985 Oct; 114(10):865-71. PubMed ID: 4082353
    [No Abstract]   [Full Text] [Related]  

  • 2. [Cardiovascular side-effects of oral contraceptives with special regard to metabolism, lipoproteins and their role in the pathogenesis of vascular complications (author's transl)].
    Ludwig H
    Schweiz Rundsch Med Prax; 1981 Mar; 70(13):549-53. PubMed ID: 7232305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and cardiovascular disease (second of two parts).
    Stadel BV
    N Engl J Med; 1981 Sep; 305(12):672-7. PubMed ID: 7022211
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolic and vascular consequences of hormonal contraception in non-diabetics].
    Basdevant A; Guy-Grand B
    Journ Annu Diabetol Hotel Dieu; 1983; ():223-37. PubMed ID: 6358613
    [No Abstract]   [Full Text] [Related]  

  • 5. Oral contraceptives and the risk of cardiovascular disease.
    Med Lett Drugs Ther; 1983 Jul; 25(640):69-70. PubMed ID: 6865850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Estrogens, progestins and blood lipids].
    Tikkanen MJ
    Duodecim; 1984; 100(22):1500-3. PubMed ID: 6518995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical and metabolic effects of oral contraceptives].
    Vázquez Hernández L; Téllez Martínez J; Hicks Gómez JJ
    Ginecol Obstet Mex; 2000 Feb; 68():64-9. PubMed ID: 10774107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic effects of estrogens and progestins.
    LaRosa JC
    Fertil Steril; 1994 Dec; 62(6 Suppl 2):140S-146S. PubMed ID: 7958008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Oral contraceptives: update].
    Fugère P
    Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
    [No Abstract]   [Full Text] [Related]  

  • 10. Estrogen, progestogens and cardiovascular risk.
    Stefanick ML
    J Reprod Med; 1999 Feb; 44(2 Suppl):221-6. PubMed ID: 11392036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral contraceptives and cardiovascular disease (first of two parts).
    Stadel BV
    N Engl J Med; 1981 Sep; 305(11):612-8. PubMed ID: 7022208
    [No Abstract]   [Full Text] [Related]  

  • 12. [Drug-induced hyperglycemia as a possible cardiovascular risk factor].
    Mammarella A; Paoletti V; Bucci O; Cavina G; Filippello CP; Iovene A; Mariani AR
    Clin Ter; 1988 Mar; 124(6):425-33. PubMed ID: 2904845
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative review of third-generation progestins.
    Kafrissen ME; Corson SL
    Int J Fertil Menopausal Stud; 1993; 38 Suppl 3():103-13. PubMed ID: 8260967
    [No Abstract]   [Full Text] [Related]  

  • 14. [Contraceptive pills; their effect on lipid and carbohydrate metabolism and on the cardiocirculatory system. Epidemiological and experimental aspects].
    Lederer J; Vastesaeger M
    Brux Med; 1977 May; 57(5):199-214. PubMed ID: 880501
    [No Abstract]   [Full Text] [Related]  

  • 15. Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
    Contraception; 1998 May; 57(5):315-24. PubMed ID: 9673838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk of thrombophlebitis during hormonal contraception].
    Ludwig H
    Ther Umsch; 1971 Aug; 28(8):516-21. PubMed ID: 5119110
    [No Abstract]   [Full Text] [Related]  

  • 17. [Estrogens and cardiovascular diseases: should current guidelines be changed?].
    Beller F; Theiss W
    Zentralbl Gynakol; 1994; 116(8):441-8. PubMed ID: 7941812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Oral contraceptives and cardiovascular disease--aspects of lipid metabolism].
    Crona N; Silfverstolpe G
    Lakartidningen; 1984 Feb; 81(6):425-7. PubMed ID: 6700305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection criteria for oral contraceptive use. Current concepts.
    Burkman RT
    J Reprod Med; 1986 Sep; 31(9 Suppl):929-33. PubMed ID: 3772913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Physiology and clinical aspects of contraceptives of the hormonal type].
    Benagiano G; Kincl FA; Rudel HH
    Minerva Med; 1968 Mar; 59(18):963-76. PubMed ID: 5646212
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.